Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CFO James William Rogers sold 31,780 shares of the firm's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $82.33, for a total value of $2,616,447.40. Following the sale, the chief financial officer now directly owns 189,320 shares in the company, valued at approximately $15,586,715.60. This represents a 14.37 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
James William Rogers also recently made the following trade(s):
- On Wednesday, February 5th, James William Rogers sold 8,712 shares of Tempus AI stock. The stock was sold at an average price of $67.57, for a total value of $588,669.84.
- On Monday, December 16th, James William Rogers sold 1,468 shares of Tempus AI stock. The shares were sold at an average price of $40.23, for a total transaction of $59,057.64.
- On Wednesday, December 11th, James William Rogers sold 83,025 shares of Tempus AI stock. The stock was sold at an average price of $42.30, for a total transaction of $3,511,957.50.
Tempus AI Stock Down 11.2 %
Shares of Tempus AI stock traded down $8.57 on Friday, hitting $68.15. The stock had a trading volume of 14,356,143 shares, compared to its average volume of 14,342,920. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45. The business's 50 day moving average is $49.75 and its two-hundred day moving average is $51.44.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TEM. ARK Investment Management LLC boosted its position in shares of Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after acquiring an additional 3,141,487 shares during the period. NEA Management Company LLC raised its stake in Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock worth $304,846,000 after purchasing an additional 813,169 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. grew its position in shares of Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Finally, Franklin Resources Inc. increased its holdings in shares of Tempus AI by 240.5% during the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the period. 24.22% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
TEM has been the topic of several analyst reports. Stifel Nicolaus lowered Tempus AI from a "buy" rating to a "hold" rating and upped their target price for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Needham & Company LLC reiterated a "buy" rating and set a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. William Blair cut shares of Tempus AI from an "outperform" rating to a "market perform" rating in a research note on Wednesday, February 12th. Wolfe Research initiated coverage on shares of Tempus AI in a report on Friday, December 13th. They set an "outperform" rating and a $60.00 target price on the stock. Finally, Guggenheim began coverage on shares of Tempus AI in a research note on Monday, December 9th. They issued a "buy" rating and a $74.00 price target for the company. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $58.55.
Check Out Our Latest Report on TEM
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
